Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Forrester

- PMLiVE

AstraZeneca hit by US Pulmicort patent ruling

Federal court says patent for inhaled steroid drug is invalid

- PMLiVE

It’s a beautiful day in the neighbourhood: The importance of data

Clinical trial data is vital for clinicians practicing evidence-based medicine, but even more compelling can be real-world data gathered from local real-world patients

- PMLiVE

Pfizer’s Bosulif gets conditional green light for CML in Europe

Follows US approval last year

- PMLiVE

NICE: Pfizer’s lung cancer drug Xalkori too expensive for NHS

Pharma company says NICE's data demands need to take ethics into account

- PMLiVE

Look who’s talking (2.0): How technology is shaping healthcare communications

Despite rhetoric to the contrary, the healthcare conversation has not changed - it’s only just started. Is technology helping to shift the dynamics of healthcare communications?

- PMLiVE

AstraZeneca settles with generic rivals in Crestor patent challenge

Blocks competition in US until May 2016

- PMLiVE

Additional 2,300 jobs to go at AstraZeneca

Soriot sets out strategy to return to growth

inVentiv invests in virtual trials

Acquires equity stake in US-based Mytrus

- PMLiVE

Former Pfizer R&D head LaMattina to advise Ziarco

He previously spent 30 years at US pharma firm

- PMLiVE

AstraZeneca cuts 1,600 jobs in overhaul of global operations

US and UK affected as Soriot pushes ahead with R&D restructuring

China: Engagement strategies

As China grows apace, digital is increasingly being used to engage both customers and patients

NHS hopes to narrow the digital divide in health

Will provide funding for new 'digital health hubs'

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links